AzTrials
AzTrials

Chronic Nonspecific Low Back PainNCT07839169

Effects of SIS Therapy in Individuals With Chronic Nonspecific Low Back Pain

A study testing SIS Therapy and Conventional Physiotherapy in people with Chronic Nonspecific Low Back Pain, run by Pamukkale University at 1 site in Turkey (Türkiye).

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Brief Summary - buraya yapıştırın Chronic nonspecific low back pain is a common condition that can cause pain, limitations in daily activities, and reduced quality of life. Exercise and conventional physiotherapy are commonly used to manage chronic low back pain. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Chronic Nonspecific Low Back Pain
What is being tested?
SIS Therapy and Conventional Physiotherapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Oct 2026to 30 Apr 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Aged between 18 and 65 years Having chronic nonspecific low back pain for at least 3 months Having a pain intensity of 4 or higher on the Visual Analog Scale (VAS) Being able to walk independently Volunteering to participate in the study and providing written informed consent

Who cannot join

  • History of lumbar spine surgery Severe neurological deficit or radiculopathy associated with disc herniation Presence of vertebral fracture, tumor, infection, or inflammatory rheumatic disease Pregnancy History of malignancy Having received physiotherapy for the lumbar region within the previous 3 months Cognitive or communication problems that may prevent compliance with the assessments
  • -

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

aysenur yılmaz, Assistant Professor, PT,PhD contact

05432833819

aysenuryilmaz@mehmetakif.edu.tr

Turkey (Türkiye)1 site
  • Aydın Şehir Hastanesi

    Aydin, Aydın, 09100

    Isıl Karatas Berkit, isilkaratasberkit@yahoo.com.tr

    Fatma taşkın

Other trials in Turkey (Türkiye)

About this study

Official title: Effects of SIS Therapy in Individuals With Chronic Nonspecific Low Back Pain: A Randomized Controlled Trial

Brief Summary - buraya yapıştırın

Chronic nonspecific low back pain is a common condition that can cause pain, limitations in daily activities, and reduced quality of life. Exercise and conventional physiotherapy are commonly used to manage chronic low back pain. SIS Therapy is a physiotherapy approach intended to reduce pain and improve movement and function.

Read more

The aim of this randomized controlled trial is to investigate the effects of SIS Therapy in individuals with chronic nonspecific low back pain and to compare these effects with conventional physiotherapy.

Participants will be randomly assigned to one of two groups. The SIS Therapy group will receive SIS Therapy together with a standard exercise program consisting of lumbar stabilization and stretching exercises. The conventional physiotherapy group will receive a program consisting of heat application, transcutaneous electrical nerve stimulation (TENS), therapeutic ultrasound, and therapeutic exercise. Both groups will receive treatment twice a week for four weeks, for a total of eight sessions, and both groups will receive the same home exercise program.

Participants will be evaluated before and after the four-week treatment period. The assessments will examine changes in pain intensity, lumbar mobility, and back extensor muscle endurance.

Read the detailed description

This study is a prospective, assessor-blinded, two-arm, parallel-group randomized controlled trial designed to investigate the effects of SIS Therapy in individuals with chronic nonspecific low back pain and to compare its effects with conventional physiotherapy.

Individuals aged 18-65 years with chronic nonspecific low back pain lasting for at least three months will be screened for eligibility. Individuals with a Visual Analog Scale (VAS) pain intensity score of 4 or higher, who are able to walk independently and who voluntarily agree to participate in the study by providing written informed consent will be included.

After enrollment, participants will be randomly allocated to one of two intervention groups in a 1:1 ratio using a computer-generated randomization sequence. Allocation concealment will be achieved using sequentially numbered, opaque, sealed envelopes prepared according to the randomization sequence by a researcher independent of the study. The researcher responsible for outcome assessments will be blinded to group allocation.

Participants allocated to the SIS Therapy group will receive SIS Therapy together with a standard exercise program consisting of lumbar stabilization and stretching exercises. Participants allocated to the conventional physiotherapy group will receive a conventional physiotherapy program consisting of heat application, transcutaneous electrical nerve stimulation (TENS), therapeutic ultrasound, and therapeutic exercise. Both groups will receive treatment twice per week for four weeks, resulting in a total of eight treatment sessions. In addition, the same home exercise program will be provided to participants in both groups.

Outcome assessments will be performed at baseline before the intervention and after completion of the four-week intervention period by the same assessor under standardized conditions.

Pain intensity will be assessed using the Visual Analog Scale (VAS). Participants will indicate the intensity of their current low back pain on a 10-cm horizontal line ranging from 0, representing no pain, to 10, representing the worst or unbearable pain.

Pressure pain threshold (PPT) will also be assessed to provide a quantitative measure of mechanical pain sensitivity. A pressure algometer will be applied perpendicular to standardized measurement sites in the lumbar paraspinal region, and pressure will be gradually increased. Participants will be instructed to indicate the moment when the sensation of pressure first becomes painful. The pressure value at this point will be recorded as the pressure pain threshold. Measurements will be repeated at the predetermined sites, and the mean value will be used for analysis. Higher PPT values will indicate a higher pressure pain threshold and lower mechanical pain sensitivity.

Lumbar flexion mobility will be evaluated using the Modified Modified Schober Test (MMST). The participant will stand in an upright position, and standardized anatomical landmarks will be identified. The change in distance between the marked points during maximal forward trunk flexion will be recorded as an indicator of lumbar flexion mobility.

Static endurance of the lumbar extensor muscles will be evaluated using the Sorensen Back Extensor Endurance Test. During the test, the pelvis and lower extremities will be stabilized while the participant maintains the upper trunk in a horizontal position for as long as possible. The duration for which the position can be maintained will be recorded in seconds, with longer durations indicating greater back extensor endurance.

Functional disability related to low back pain will be evaluated using the Oswestry Disability Index (ODI). The ODI will be used to determine the degree to which low back pain affects participants' daily activities and functional status.

A total of 60 participants are planned to be enrolled in the study, with 30 participants allocated to each group. The sample size was determined based on an alpha level of 0.05, statistical power of 80%, and an anticipated effect size of Cohen's d = 0.80. The target sample size was increased to account for an anticipated dropout rate of approximately 15%.

The primary objective of the study is to determine whether SIS Therapy, when combined with an exercise program, produces changes in pain intensity compared with conventional physiotherapy in individuals with chronic nonspecific low back pain. Secondary objectives include investigating changes in pressure pain threshold, functional disability, lumbar mobility, and back extensor muscle endurance following the intervention.

Being tested
SIS Therapy, Conventional Physiotherapy
Keywords
Exercise Therapy, Rehabilitation, Physiotherapy, Physical Therapy, Pain, Chronic Nonspecific Low Back Pain
Medical subject headings
Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SIS TherapyOther

    Participants assigned to the experimental group will receive SIS Therapy in addition to a standard exercise program consisting of lumbar stabilization and stretching exercises. Treatment will be administered twice weekly for four weeks, for a total of eight treatment sessions. Participants will also receive a home exercise program.

  • Conventional PhysiotherapyOther

    Participants assigned to the active comparator group will receive conventional physiotherapy consisting of heat application, transcutaneous electrical nerve stimulation (TENS), therapeutic ultrasound, and therapeutic exercise. Treatment will be administered twice weekly for four weeks, for a total of eight treatment sessions. Participants will also receive the same home exercise program provided to the experimental group.

Study groups in NCT07839169
Study groupRoleWhat they receive
SIS Therapy GroupExperimentalParticipants in this group will receive SIS Therapy in addition to a standard exercise program consisting of lumbar stabilization and stretching exercises. The intervention will be administered twice weekly for four weeks, for a total of eight treatment sessions. Participants will also receive a home exercise program.
Receives: Other: SIS Therapy
Conventional Physiotherapy GroupActive comparatorParticipants in this group will receive conventional physiotherapy consisting of heat application, transcutaneous electrical nerve stimulation (TENS), therapeutic ultrasound, and therapeutic exercise. The intervention will be administered twice weekly for four weeks, for a total of eight treatment sessions. Participants will also receive the same home exercise program provided to the SIS Therapy group.
Receives: Other: Conventional Physiotherapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Pain Intensity Assessed by the Visual Analog Scale (VAS)

    Pain intensity will be assessed using the Visual Analog Scale (VAS). Participants will rate their current low back pain on a 10-cm horizontal scale ranging from 0 (no pain) to 10 (unbearable pain). Higher scores indicate greater pain intensity. Change in VAS score from baseline to the end of the 4-week intervention will be evaluated.

    Measured: Baseline and immediately after the 4-week intervention

  2. Change in Pressure Pain Threshold Assessed by Pressure Algometry

    Pressure pain threshold (PPT) will be assessed using a pressure algometer at standardized measurement sites in the lumbar paraspinal region. Pressure will be gradually increased until the participant first reports that the pressure sensation has become painful. The pressure value at this point will be recorded as the PPT. Higher PPT values indicate lower mechanical pain sensitivity.

    Measured: Pressure pain threshold (PPT) will be assessed using a pressure algometer at standardized measurement sites in the lumbar paraspinal region. Pressure will be gradually increased until the participant first reports that the pressure sensation has become p

Secondary outcomes (3)
  1. Change in Functional Disability Assessed by the Oswestry Disability Index (ODI)

    Change in Functional Disability Assessed by the Oswestry Disability Index (ODI)

    Measured: Baseline and immediately after the 4-week intervention

  2. Change in Lumbar Flexion Mobility Assessed by the Modified Modified Schober Test (MMST)

    Lumbar flexion mobility will be assessed using the Modified Modified Schober Test (MMST). The change in distance between standardized anatomical landmarks during maximal forward trunk flexion will be recorded in centimeters. A greater increase in distance indicates greater lumbar flexion mobility.

    Measured: Baseline and immediately after the 4-week intervention

  3. Change in Back Extensor Muscle Endurance Assessed by the Sorensen Test

    Back extensor muscle endurance will be assessed using the Sorensen Back Extensor Endurance Test. The duration for which the participant can maintain the standardized horizontal trunk position will be recorded in seconds. Longer durations indicate greater back extensor muscle endurance.

    Measured: Baseline and immediately after the 4-week intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Sep 2026
  2. Study start1 Oct 2026 (estimated)
  3. Primary completion30 Dec 2026 (estimated)
  4. Study completion30 Apr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomly assigned in a 1:1 ratio to one of two parallel intervention groups: the SIS Therapy group or the conventional physiotherapy group. Both groups will receive treatment twice weekly for four weeks, for a total of eight treatment sessions.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07839169
Sponsor's protocol ID
SIS-LBP-2026-01
Status last verified
Sep 2026
First submitted
18 Sep 2026
Last updated
24 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data (IPD) will not be shared with other researchers. Participant data will be coded and stored securely, with access restricted to the research team. The data will be used solely for the purposes of this study and the reporting of its scientific results.

Publications

  • George SZ, Fritz JM, Silfies SP, Schneider MJ, Beneciuk JM, Lentz TA, Gilliam JR, Hendren S, Norman KS. Interventions for the Management of Acute and Chronic Low Back Pain: Revision 2021. J Orthop Sports Phys Ther. 2021 Nov;51(11):CPG1-CPG60. doi: 10.2519/jospt.2021.0304.

    PubMed 34719942
  • Hartvigsen J, Hancock MJ, Kongsted A, Louw Q, Ferreira ML, Genevay S, Hoy D, Karppinen J, Pransky G, Sieper J, Smeets RJ, Underwood M; Lancet Low Back Pain Series Working Group. What low back pain is and why we need to pay attention. Lancet. 2018 Jun 9;391(10137):2356-2367. doi: 10.1016/S0140-6736(18)30480-X. Epub 2018 Mar 21.

    PubMed 29573870

Questions about this trial

What is this clinical trial studying?

A study testing SIS Therapy and Conventional Physiotherapy in people with Chronic Nonspecific Low Back Pain, run by Pamukkale University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 24 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact aysenur yılmaz, Assistant Professor, PT,PhD (05432833819, aysenuryilmaz@mehmetakif.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Pain Intensity Assessed by the Visual Analog Scale (VAS) (time frame: Baseline and immediately after the 4-week intervention). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07839169, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in